European Society for Radiotherapy and Oncology (ESTRO) posted on LinkedIn:
“At ESTRO25, a heated debate unfolded: “CBCT-based fast adaptation workflows will supersede MR-Linac usage.”
With strong arguments on both sides, the audience shifted from 72% in favour to a near 50/50 split by the end.
Read the full Congress Report by the ESTRO Positioning and Immobilisation Focus Group to explore the clinical, economic, and strategic dimensions of this key discussion.”
More posts featuring European Society for Radiotherapy and Oncology.